Scholarly Index
Lucia Del Mastro
Ospedale Policlinico San Martino; 19,114 total citations; 589 total publications; best world rank #47
Ospedale Policlinico San Martino
19,114Total citations
589Total publications
67H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Breast Cancer Treatment Studies | Lifetime | 287 | IT 21 | 99.06 |
| Cancer Treatment and Pharmacology | Lifetime | 353 | IT 27 | 98.97 |
| Advanced Breast Cancer Therapies | Lifetime | 161 | IT 11 | 98.59 |
| HER2/EGFR in Cancer Research | Lifetime | 456 | IT 27 | 98.06 |
| Estrogen and related hormone effects | Lifetime | 691 | IT 26 | 97.63 |
| Cancer Risks and Factors | Lifetime | 433 | IT 21 | 97.12 |
| Neutropenia and Cancer Infections | Lifetime | 423 | IT 24 | 96.51 |
| Chemotherapy-induced cardiotoxicity and mitigation | Lifetime | 638 | IT 65 | 90.18 |
| Chemotherapy-related skin toxicity | Lifetime | 741 | IT 51 | 82.52 |
| Male Breast Health Studies | Lifetime | 273 | IT 32 | 77.65 |
| Breast Cancer Treatment Studies | 2021-2025 | 47 | IT 5 | 99.34 |
| Cancer Treatment and Pharmacology | 2021-2025 | 64 | IT 5 | 98.66 |
| Advanced Breast Cancer Therapies | 2021-2025 | 76 | IT 5 | 98.74 |
| Estrogen and related hormone effects | 2021-2025 | 50 | IT 5 | 95.49 |
| HER2/EGFR in Cancer Research | 2021-2025 | 138 | IT 14 | 97.98 |
| Cancer Genomics and Diagnostics | 2021-2025 | 642 | IT 52 | 96.03 |
| BRCA gene mutations in cancer | 2021-2025 | 435 | IT 26 | 89.51 |
| Cancer Risks and Factors | 2021-2025 | 303 | IT 16 | 87.61 |